Literature DB >> 18693102

Comparative study on the aristolochic acid I content of Herba Asarifor safe use.

Zhong-Zhen Zhao1, Zhi-Tao Liang, Zhi-Hong Jiang, Kelvin Sze-Yin Leung, Chi-Leung Chan, Hon-Yee Chan, Jaime Sin, Tim-On Man, Kwok-Wai Law.   

Abstract

Herba Asari (Xixin, Manchurian Wildginger, Asarum spp.) is a traditional Chinese medicinal herb commonly used as a crude drug and an ingredient in patent medicines. The herb contains aristolochic acid I (AA-I), which has recently caused several incidents of poisoning in Hong Kong. Therefore, the safe use of Asarum is questionable. The present study was undertaken to assess the levels of AA-I using liquid chromatography-mass spectrometry (LC/MS) indifferent medicinal parts of Herba Asari and some proprietary Chinese medicines (PCM) containing it as an ingredient. The AA-I content in the aerial and root portions were compared, in the form of water and methanolic extracts. The results showed that all the aerial portions of Herba Asari generally contain higher levels of AA-I than the roots (in water extract: 0.0870.06 microg/g of root and 0.3270.021 microg/g of aerial), and the methanolic extracts typically contained more AA-I than the water extracts. Moreover, all the three PCM studies showed negligible amounts of AA-I(containing 0.0370.006 microg/g). Therefore, the root portion of Herba Asari was recommended for prescription as a decoction instead of grinding it into powder for oral administration.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18693102     DOI: 10.1016/j.phymed.2008.06.006

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  7 in total

1.  Studies on morphology and aristolochic acid analogue constituents of Asarum campaniflorum and a comparison with two official species of Asari radix et rhizoma.

Authors:  Yao-Li Li; Min Tian; Jie Yu; Ming-Ying Shang; Shao-Qing Cai
Journal:  J Nat Med       Date:  2010-07-17       Impact factor: 2.343

2.  Comparative study of the contents of analogues of aristolochic acid in two kinds of Aristolochiae Fructus by high-performance liquid chromatography.

Authors:  Yu-Qiong Xu; Xiao-Wei Li; Guang-Xue Liu; Xuan Wang; Ming-Ying Shang; Xiao-Mei Li; Shao-Qing Cai
Journal:  J Nat Med       Date:  2012-04-08       Impact factor: 2.343

3.  Medicinally Used Asarum Species: High-Resolution LC-MS Analysis of Aristolochic Acid Analogs and In vitro Toxicity Screening in HK-2 Cells.

Authors:  Johanna Michl; Olusheyi Bello; Geoffrey C Kite; Monique S J Simmonds; Michael Heinrich
Journal:  Front Pharmacol       Date:  2017-05-22       Impact factor: 5.810

4.  Asari Radix et Rhizoma consumption lacks relevance for hepatocellular carcinoma in patients: A retrospective cohort study.

Authors:  Zhi-E Fang; Yuming Guo; Zhilei Wang; Tingting He; Jiabo Wang; Zhaofang Bai; Xiaohe Xiao
Journal:  Chin Herb Med       Date:  2022-03-26

5.  Fructus mume formula in the treatment of type 2 diabetes mellitus: a randomized controlled pilot trial.

Authors:  Xiang Tu; Chunguang Xie; Fei Wang; Qiu Chen; Zhihuang Zuo; Qiong Zhang; Xingshuan Wang; Sen Zhong; James B Jordan
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-07       Impact factor: 2.629

6.  In Vitro and In Vivo Evaluation of Polyherbal Formulation against Russell's Viper and Cobra Venom and Screening of Bioactive Components by Docking Studies.

Authors:  G Sakthivel; Amitabha Dey; Kh Nongalleima; Murthy Chavali; R S Rimal Isaac; N Surjit Singh; Lokesh Deb
Journal:  Evid Based Complement Alternat Med       Date:  2013-02-28       Impact factor: 2.629

7.  New Contributions to Asarum Powder on Immunology Related Toxicity Effects in Lung.

Authors:  Yamin Li; Lintao Han; Chunhua Huang; Wangqiang Dai; Guangyu Tian; Fang Huang; Jingjing Li; Jinwei Liu; Qiong Wang; Zhenxiang Zhou
Journal:  Evid Based Complement Alternat Med       Date:  2018-09-02       Impact factor: 2.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.